Saturday 22 July 2017

Elan gets boost with Tysabri test

PHARMACEUTICALS SURVEY BUILDING RECESSION INVESTMENT BANKING

A test that could help patients planning to use multiple sclerosis drug Tysabri, the treatment that is owned by Irish firm Elan and US-based Biogen-Idec, has got marketing approval in Europe.

The test is used to detect the presence of antibodies for a virus that is known to increase the incidence of a potentially deadly brain disease in patients using Tysabri.

Retailers not so hot on trading outlook

RETAIL Ireland has released a survey that found retailers remain pessimistic about the trading outlook. Some 56pc of respondents rated the prospects for their business over the three months March to May as poor or very poor; some 27pc rate it as average and 17pc rate it as good for this period.

Construction bill 'is seriously flawed'

THE CONSTRUCTION Contracts Bill, which was debated in the Seanad yesterday, is "seriously flawed", according to the Irish Concrete Federation (ICF), which represents about 100 manufacturing businesses. ICF chief executive Gerry Farrell claimed the latest revisions to the proposed legislation had watered down the original bill.

Iceland returned to growth in 2010

ICELAND'S economy shrank again in the final part of last year after growing in the third quarter, data showed, but it closed 2010 with its first year-on-year growth since the country was hit by a brutal recession. Gross domestic product shrank 1.5pc in the fourth quarter from the previous three months, the statistics office said. Year-on-year the economy grew 0.1pc.

Traders to get day in court over bonuses

MORE than 100 City traders suing Commerzbank for about £40m (€46m) in unpaid bonuses will have their claim heard after the UK Court of Appeal dismissed the German bank's attempt to have their case dismissed. Three senior appeal judges upheld an earlier High Court ruling that two separate lawsuits should go to full trial.

Irish Independent

Promoted articles

Also in Business